Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1995
03/09/1995CA2169950A1 Monoclonal antibody that induces apoptosis
03/09/1995CA2169645A1 Non-nucleotide containing enzymatic nucleic acid
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2169466A1 Methods for screening antiestrogen compounds
03/09/1995CA2169094A1 Medium chain-specific thioesterases
03/09/1995CA2168565A1 T cell epitopes of ryegrass pollen allergen
03/09/1995CA2158934A1 Methods of suppressing immune response by gene therapy
03/09/1995CA2158933A1 Methods of suppressing graft rejection
03/09/1995CA2158932A1 Methods of suppressing autoimmune response
03/09/1995CA2118990A1 Catalytic antibodies hydrolyzing acylated carbohydrates with a regio-and stereoselective manner
03/08/1995EP0641861A2 Process for producing hydrophobic polypeptides, proteins or peptides
03/08/1995EP0641860A2 A strain of saccharomyces cerevisiae expressing the gene encoding potassium transporter mink
03/08/1995EP0641801A2 Catalytic antibodies hydrolyzing acylated carbohydrates with a region- and stereoselective manner
03/08/1995EP0641391A1 Loop structures
03/08/1995EP0641390A1 Chemical method for the analysis of dna sequences.
03/08/1995EP0641386A1 Human 5ht-1b receptor (serotonin receptor), process for preparing the same and its uses
03/08/1995EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens
03/08/1995EP0641384A1 VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs
03/08/1995EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
03/08/1995EP0641353A1 Anti-sense oligonucleotides for isotype-specific suppression of immunoglobulin production
03/08/1995EP0641215A1 Protease-resistant thrombomodulin analogs
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/08/1995EP0484382B1 Feline calicivirus capsid protein and nucleotide sequence
03/08/1995EP0295286B1 Method for the production of salmon growth hormone using a synthetic gene
03/08/1995CN1099802A Tumor necrosis factor muteins
03/08/1995CN1099801A Peptides
03/08/1995CN1099800A Fungus resistant plants
03/08/1995CN1099799A Process for preparing and purifying alpha-interferon
03/08/1995CN1099798A Hepatitis a virus vaccine
03/08/1995CA2117616A1 Strain of saccharomyces cerevisiae expressing the gene encoding potassium transporter mink
03/07/1995US5395929 Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
03/07/1995US5395928 Elution with controlled concentration of buffer with soft base counterion
03/07/1995US5395927 DNA-fragment having the cyclodextrin glycosyltranferase gene
03/07/1995US5395922 Yeast processing system
03/07/1995US5395767 Isolated nucleic acid
03/07/1995US5395764 Promoter of the gene which codes for the pilinic subunit fim3 of Bordetella pertussis and its use for the expression in Bordetella of the genes which code for a protein of interest
03/07/1995US5395763 Chromosomal expression vector
03/07/1995US5395761 Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith
03/07/1995US5395760 Isolated dna sequence encoding selected amino acid sequences
03/07/1995US5395759 Vaccines, medical diagnosis
03/07/1995US5395756 Production of acidic FGF protein
03/07/1995US5395750 Constructing a plurality of synthetic genes, expressing proteins encoded by genes in a microorganism and contacting proteins with antigen to obtain antibody binding to the antigen
03/07/1995US5395614 Vaccines reducing severity of blood-stage malaria
03/03/1995CA2131433A1 Mice deficient in neurotrophin receptors
03/02/1995WO1995006253A1 Assay device with captured particle reagent
03/02/1995WO1995006250A1 Molecular clones producing recombinant dna antigens of the hards virus
03/02/1995WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995WO1995006137A1 Detection of genes
03/02/1995WO1995006129A2 Transfection process
03/02/1995WO1995006128A2 Fertile, transgenic maize plants and methods for their production
03/02/1995WO1995006127A1 Method for the production of transgenic cereals
03/02/1995WO1995006126A1 Production of trehalose in plants
03/02/1995WO1995006124A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995WO1995006123A1 Detection and prevention of mycoplasma hominis infection
03/02/1995WO1995006122A2 Recombinant alternaria alternata allergenes
03/02/1995WO1995006121A2 Recombinant cladosporium herbarum allergens
03/02/1995WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy
03/02/1995WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody
03/02/1995WO1995006118A1 Expression control sequences of the p-selectin gene
03/02/1995WO1995006117A1 Human 5-ht2 receptor
03/02/1995WO1995006113A1 Novel tyrosine kinase
03/02/1995WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995006064A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i
03/02/1995WO1995006059A1 Aqueous multiple-phase isolation of polypeptide
03/02/1995WO1995006056A1 Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same
03/02/1995WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005851A1 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF
03/02/1995WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005835A1 Gene therapy for solid tumors, papillomas and warts
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995005750A1 Cell death regulator
03/02/1995WO1995005738A1 Anticancer agents and apoptosis
03/02/1995WO1995005732A1 Materials and methods for producing plants with single-sex flowers
03/02/1995WO1995005731A1 Gene conferring disease resistance to plants
03/02/1995WO1995003418A3 Recombinant bcg vaccines
03/02/1995WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/02/1995WO1995003410A3 Guanylatcyclase activating peptide i (gcap-i) coding gene
03/02/1995WO1995001437A3 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
03/02/1995WO1994029456A3 Herpes simplex virus type-2 protease
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995WO1993015229A3 Amplification of assay reporters by nucleic acid replication
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995DE4407859C1 Vector for liver-specific gene therapy
03/02/1995DE4333805A1 Process for extraction of nucleic acids and method for detecting specified nucleic acid sequences
03/02/1995DE4325262A1 Resistance inducer, process for its preparation, use for controlling pests
03/02/1995CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995CA2170356A1 Recombinant cladosporium herbarum allergens
03/02/1995CA2170355A1 Recombinant alternaria alternata allergenes
03/02/1995CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995CA2170260A1 Fertile, transgenic maize plants and methods for their production
03/02/1995CA2170249A1 Assay device with captured particle reagent
03/02/1995CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy
03/02/1995CA2169941A1 Expression control sequences of the p-selectin gene
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169849A1 Accessory factor function for interferon gamma and its receptor
03/02/1995CA2169828A1 Transfection process
03/02/1995CA2169755A1 Detection and prevention of mycoplasma hominis infection